Sep 6, 2021
By: Rounak Jain
Credit: BCCL
Entered into an agreement with Citius Pharmaceuticals to sell its rights to anti-cancer agent E7777, for a total consideration of $150 million.
Credit: Dr. Reddy's Laboratories
Its subsidiary entered into a deal with Strand Life Sciences to acquire a 80.3 percent stake by March 2023, for a total investment of ₹553 crore.
Credit: Reliance Industries
Reports suggest that the government will announce a production-linked incentive scheme for the auto sector this week.
Credit: BCCL
Its disbursements in August rose 57 percent to ₹2,150 crore year-on-year, while collection efficiency stood at 97 percent.
Credit: M&M Financial Services
To seek shareholders’ approval to raise ₹18,000 crore via bonds or debentures.
Credit: NTPC
Raised ₹100 crore through preferential issue of equity shares.
Credit: BCCL
Expanded its portfolio with the rollout of credit cards in partnership with Visa.
Credit: Federal Bank
Bagged an order worth ₹1,570 crore in West Bengal.
Credit: Ashoka Buildcon
Received an order worth ₹1,039 crore from Chennai Petroleum Corporation.
Credit: Engineers India
Its board has approved a fundraising of ₹750 crore.
Credit: HFCL